Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Article
Nature 455, 679-683 (17 August 2008) | doi:10.1038/nature07260;
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Laboratory Technician (Pharmaceutics)
- Alliance Institute of Advanced Pharmacy and Health Sciences
- Hyderabad 500038 India
Professor of Psychosomatic Medicine (W2)
- The University Hospital Jena, Institute of Psychosocial Medicine and Psychotherapy
- Jena Germany
Modelling Myc inhibition as a cancer therapy
Myc is a pleiotropic basic helix–loop–helix leucine zipper transcription factor that coordinates expression of the diverse intracellular and extracellular programs that together are necessary for growth and expansion of somatic cells. In principle, this makes inhibition of Myc an attractive pharmacological approach for treating diverse types of cancer.
&
Abstract
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
